SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-18-004285
Filing Date
2018-01-18
Accepted
2018-01-18 16:53:07
Documents
2
Period of Report
2018-01-17

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1614
2 EX-24 DOCUMENT attachment1.htm EX-24 3562
  Complete submission text file 0001209191-18-004285.txt   6616
Mailing Address 50 PEMBROKE ROAD DUBLIN L2 2
Business Address
Lynch Thomas G (Reporting) CIK: 0001360000 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36754 | Film No.: 18534470

Mailing Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130
Business Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130 (858) 550-1900
Evofem Biosciences, Inc. (Issuer) CIK: 0001618835 (see all company filings)

IRS No.: 208527075 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations